Vitor-Belfort-UFC-on-FX-7

Former UFC light heavyweight champion Vitor Belfort received a therapeutic-use exemption (TUE) for testosterone replacement therapy (TRT) in his UFC on FX 7 bout with Michael Bisping.

Last week, rumours were circulating that Belfort had failed his post-fight urine test after Dana White confirmed that someone on the card had failed a test, but denied it was “The Phenom”. Then today, US website Tatame.com revealed that UFC lightweight Thiago Tavares was the fighter who failed his drug test following the event.

But then later today after the news regarding Thiago Tavares, it was revealed by the UFC that Belfort’s drug test results were negative and in fact he received a therapeutic-use exemption (TUE) for testosterone replacement therapy (TRT) in his TKO win over UK’s Michael Bisping.

Zuffa released a statement saying: “Belfort has been on a medically approved testosterone replacement therapy (TRT) regimen under the supervision of a medical doctor from the State of Nevada, after being diagnosed with hypogonadism, or low testosterone. The purpose of a medically administered TRT regimen is to allow patients with hypogonadism to maintain testosterone levels within a range that is normal for an adult male.”

This will now explain the strange response to questions about TRT during an interview with ESPN prior to his UFC on FX 7 fight with Bisping.

There is no news on how long “The Phenom” has been on testosterone replacement therapy (TRT), but it’s believed there was a fighter that still remains unnamed that was granted a therapeutic-use exemption (TUE) for TRT at UFC 152, the night Belfort lost to light heavyweight champion Jon Jones.

Stay tuned to The Fight Lounge for more news and updates on this story.

By Robert Riley

Facebook: www.facebook.com/robertukmma
Twitter: @robert_ukmma

UK MMA Journalist, Writer, Promoter and Matchmaker sponsored by:

Banned Fightwear: www.bannedfightwear.com